lorcaserin   Click here for help

GtoPdb Ligand ID: 2941

Synonyms: APD-356 | Belviq®
Approved drug
lorcaserin is an approved drug (FDA (2012))
Compound class: Synthetic organic
Comment: Lorcaserin is a selective, orally available and CNS active serotonin 2C receptor agonist that modulates appetite [2-3,5-6]. Cardiovascular safety in obese/overweight patients was reported by Bohula et al. (2018) [1].
Clinical formulations contain lorcaserin hydrochloride (PubChem CID 11673085).
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 1
Hydrogen bond donors 1
Rotatable bonds 0
Topological polar surface area 12.03
Molecular weight 195.08
XLogP 2.45
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES Clc1ccc2c(c1)C(C)CNCC2
Isomeric SMILES Clc1ccc2c(c1)[C@@H](C)CNCC2
InChI InChI=1S/C11H14ClN/c1-8-7-13-5-4-9-2-3-10(12)6-11(8)9/h2-3,6,8,13H,4-5,7H2,1H3/t8-/m0/s1
InChI Key XTTZERNUQAFMOF-QMMMGPOBSA-N
Selectivity at GPCRs
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
5-HT2C receptor Primary target of this compound Hs Agonist Full agonist 7.8 pKi - 5
pKi 7.8 [5]
5-HT2A receptor Hs Agonist Full agonist 6.8 pKi - 5
pKi 6.8 [5]
5-HT2B receptor Hs Agonist Full agonist 6.8 pKi - 5
pKi 6.8 [5]
5-HT2C receptor Primary target of this compound Hs Agonist Full agonist 8.1 pEC50 - 5
pEC50 8.1 [5]
5-HT2A receptor Hs Agonist Full agonist 6.8 pEC50 - 5
pEC50 6.8 [5]
5-HT2B receptor Hs Agonist Full agonist 6.0 pEC50 - 5
pEC50 6.0 [5]
5-HT2C receptor Primary target of this compound Hs Agonist Agonist 8.2 pIC50 - 4
pIC50 8.2 (IC50 5.8x10-9 M) [4]
Description: IP accumulation assay.